Xenothera
Odile Duvaux is the Founder, CEO, and current Chairman of XENOTHERA, a biotechnology start-up focusing on innovative xenotherapy products. Prior to founding XENOTHERA, Odile worked as a Partner at DMJ Consultants, where Odile built and supported highly performing executive teams. Odile also served as Directeur de la Communication Interne at Leroy Merlin and Chargée de recherche at Institut Pasteur Lille. With a background in molecular biology and a doctorate in medicine, Odile has a strong foundation in research and healthcare.
This person is not in any teams
Xenothera
Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments. Xenothera creates new therapeutic modes in numerous domains from immunomodulation to infectious diseases.Xenothera's technological platform is built on a double expertise of animal genetics and mastery of immunology processes. It renovatespassive immunotherapy by marketing a new generation of hyperimmune polyclonal sera.Xenothera’s platform ensures short-time development thanks to their mastery of the entire process, from animal genetics, choice of the immunogen, selection, and purification of interesting immunoglobulins, and access to market authorization in accelerated timescale.